Cancers : Impact Factor & More
eISSN: 2072-6694pISSN: 2072-6694
Open AccessShare this on:
Key Metrics
CiteScore 
5.8
Impact Factor
5 - 10
Scite Index
0.90 5-Year SI
SNIP
1.27
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancers
Cancers Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Semi-monthly |
| Article Processing Charges | CHF 2600 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Cancers ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancers
Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2− Early Breast Cancer
- 7 Aug 2026
- Cancers
Pathological Pathways of Olfactory Neuroblastoma: From Molecular Mechanisms to Targeted Therapy: A Narrative Review
- 5 Aug 2026
- Cancers
Checkpoint Blockade and Acquired Humoral Immune Dysregulation: Emerging Evidence for Antibody Deficiency During Long-Term PD-1/PD-L1 Inhibition
- 1 Aug 2026
- Cancers
Live Biotherapeutic Zowell Reprograms Microbiota–Lipid Crosstalk to Enhance Cisplatin Efficacy in Lung Cancer
- 30 Jul 2026
- Cancers
Trends, Disparities, and Forecasts in Co-Recorded Pancreatic Cancer and Cerebrovascular Disease Mortality in the United States, 1999–2024
- 28 Jul 2026
- Cancers
Circulating Thioredoxin 1 as an Adjunct to Mammography for Breast Cancer Detection: A Multicenter Clinical Validation Study
- 27 Jul 2026
- Cancers
Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2− Early Breast Cancer
- 7 Aug 2026
- Cancers
Pathological Pathways of Olfactory Neuroblastoma: From Molecular Mechanisms to Targeted Therapy: A Narrative Review
- 5 Aug 2026
- Cancers
Checkpoint Blockade and Acquired Humoral Immune Dysregulation: Emerging Evidence for Antibody Deficiency During Long-Term PD-1/PD-L1 Inhibition
- 1 Aug 2026
- Cancers
Live Biotherapeutic Zowell Reprograms Microbiota–Lipid Crosstalk to Enhance Cisplatin Efficacy in Lung Cancer
- 30 Jul 2026
- Cancers
Trends, Disparities, and Forecasts in Co-Recorded Pancreatic Cancer and Cerebrovascular Disease Mortality in the United States, 1999–2024
- 28 Jul 2026
- Cancers
Circulating Thioredoxin 1 as an Adjunct to Mammography for Breast Cancer Detection: A Multicenter Clinical Validation Study
- 27 Jul 2026
- Cancers
FAQs on Cancers
How long has Cancers been actively publishing? 
What is the publishing frequency of Cancers?
How many articles did Cancers publish last year?
What is the eISSN & pISSN for Cancers?
What is Citescore for Cancers?
What is SNIP score for Cancers?
Who is the publisher of Cancers?
